bibliographic entry 4978101 [be/4978101]
https://w3id.org/oc/corpus/be/4978101

is a
content
  • Kristen AV, Biener M, Hegenbart U, Hardt S, Schnabel PA, Rocken C et al. Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis. Int J Cardiol 2014; 176: 1113–1115. PMID: 25115253
references